Biogen and Eisai have announced the decision to discontinue the global Phase III trials of aducanumab for Alzheimer’s disease.
Browsing: mild cognitive impairment
Results of a recent study indicate that regular consumption of mushrooms may decrease the risk of mild cognitive impairment.
A recently published study has suggested that a noninvasive eye scan may help detect signs of Alzheimer’s disease in a matter of seconds.
Results from AAIC have revealed significant reductions in the risk of MCI and the combination of MCI and dementia through lowering systolic blood pressure.
Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer’s disease
Discover how transcranial stimulation may be used as a therapy for cognitive impairment and Alzheimer’s disease in this review article from Neurodegenerative Disease Management
In this interview, Collin tells us about his research, how neuroimaging could be utilized to predict progression from mild cognitive impairment to AD.
In a podcast recorded live at AAIC in London, Kim Mueller talks about her group’s novel study; the largest prospective, longitudinal study of spontaneous speech samples in a study group of its kind.
Brain training game improves memory and maintains motivation in people with mild cognitive impairment.
Immunotherapy for mild cognitive impairment patients: a role for omega-3 fatty acids in improving innate immunity against amyloid-beta
Milan Fiala and Matteo Pellegrini review current research that indicates a role for omega-3 fatty acids in slowing the progression of mild cognitive impairment.
Population-based cohort study also shows that computer use and social activities can reduce risk in APOE ε4 carriers.